⌘K

Home/Filings/4/0001209191-17-062464

4//SEC Filing

Bonner Michael 4

Accession 0001209191-17-062464

CIK 0001087294other

View on SEC.gov Company Profile

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 5:15 PM ET

Size

4.4 KB

Accession

0001209191-17-062464

Insider Transaction Report

Form 4

Period: 2017-11-22

CUMBERLAND PHARMACEUTICALS INCCPIX

Chief Financial Officer

Transactions

Purchase
Common Stock
2017-11-22$7.81/sh+250$1,953→ 15,697 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

CUMBERLAND PHARMACEUTICALS INC

CIK 0001087294

Entity typeother

Related Parties

1

filerCIK 0001666790

Filing Metadata

Form type: 4
Filed: Nov 23, 7:00 PM ET
Accepted: Nov 24, 5:15 PM ET
Size: 4.4 KB

View on SEC.gov